Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Bibliographic Details
Main Authors: Bennett, Nancy M., Pilishvili, Tamara, Whitney, Cynthia G., Moore, Matthew, Gierke, Ryan, Harris, Aaron M.
Format: Online
Language:English
Published: U.S. Centers for Disease Control 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604951/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604951/

Similar Items